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ABSTRACT
Classifying Symptom Change in Eating Disorders: Clinical Significance Metrics for the Change
in Eating Disorder Symptoms Scale

Anthony D. Hwang
Department of Psychology
Doctor of Philosophy

Despite well-established diagnostic measures and measures of specific dimensions of eating
disorder symptomatology, little work has been done to develop a brief, comprehensive, and valid
measure for assessing change in eating disorder symptoms. Further, empirically-supported
change indices to assess treatment progression and outcome have not yet been developed. The
Change in Eating Disorder Symptoms Scale (CHEDS) is a new comprehensive measure
designed to assess progress and change during treatment in persons with diagnoses on the eating
disorder spectrum. Previous studies have demonstrated the subscale structure, reliability, and
validity of the CHEDS. This study determined clinically significant change criteria for the
CHEDS to complement the studies that have supported the CHEDS as a reliable and valid
measure of eating disorder symptomatology. The CHEDS was also compared to a life
functioning scale, the Clinical Impairment Assessment. A reliable change index (RCI) was
developed, which generated an inferential statistic that estimates the magnitude of change in a
score necessary for a change score to be considered statistically reliable. A cutscore was also
developed, which differentiates between functional and dysfunctional populations, between
eating disordered clinical subjects and non-clinical subjects. Trajectories were identified using
hierarchical linear modeling methods for use in conjunction with clinical significance criteria to
aid in the tracking of symptoms during treatment, treatment decision-making, and tailoring
treatment according to expected and observed progress. The clinical significance change criteria
were then applied to the clinical sample to determine change patterns descriptive of recovered,
reliable improvement, deterioration, and no change. Finally, a scoring program with clinical
significance change criteria and trajectory analyses for total and subscale scores was developed.

KEYWORDS: Change in Eating Disorder Symptoms Scale, eating disorders, anorexia nervosa,
bulimia nervosa, eating disorder not-otherwise-specified, clinically significant change,
hierarchical linear modeling, psychometric change indices, outcome, reliable change index.
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1
Classifying Symptom Change in Eating Disorders:
Clinical Significance Metrics for the Change in Eating Disorder Symptoms Scale
There is no comprehensive measure for eating disorders that can be used on a session-bysession basis with empirically-validated change indices to gauge progress. Moreover, recovery
from eating disorders is not well-defined in the literature, as noted by Jarman and Walsh (1999),
who state that there is “an absence of an agreed upon definition of the term recovered within the
eating disorder literature…[and that clinicians] often make implicit assumptions of the definition
and meaning of recovery” (p. 775).
The current assessment of change during treatment in eating disorder research is
primarily categorical, based on whether or not a diagnostic threshold is reached for a disorder
(Keel, Mitchell, Miller, et al., 1999). The typical research definition of eating disorder recovery
is defined and determined by patients moving from meeting to not meeting established
diagnostic criteria for an eating disorder. Numerous efficacy and effectiveness studies of
treatments for eating disorders have employed this definition of outcome. The utilization of a
diagnostic criterion as an indicator of change is beneficial as it provides a clearer distinction
between those who do and do not meet criteria for an eating disorder and can provide a clear
determination of outcome in patients. However, this method of defining treatment progress has
various shortcomings, outlined below. Unidimensional measures, measures which assess a
specific dimension of eating disorders, have also been used to assess change in eating disorder
symptomatology during treatment but are, by design, limited to a single or very few symptom
domains.
A comprehensive measure of eating disorder symptoms, which goes beyond current
methods of assessing eating disorder symptoms, is needed. This study sought to develop change
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indices for the Change in Eating Disorder Symptoms Scale (CHEDS), which was designed for
session-by-session tracking of eating disorder symptom change. The CHEDS utilizes a different
method of determining symptom change and outcome that is based on comprehensive symptoms
of eating disorders, linked to tracking changes in symptomatology to circumvent the drawbacks
of utilizing a categorical, diagnostic based determination of outcome. The previous absence of a
comprehensive tracking and outcome eating disorder measure with change indices results in a
clarion call for its development.
Existing Measures of Eating Disorders
Various types of eating disorder measures are currently used. Each type was developed
for various purposes. Diagnostic measures are instruments designed to assess the presence or
absence of an eating disorder based upon diagnostic criteria typically derived from the
Diagnostic and Statistical Manual for Mental Disorders (DSM: American Psychological
Association, 2000) or the International Classification of Disease (ICD: Medical Management
Institute, 2008). These instruments classify individuals into mutually exclusive categories of
either meeting criteria for a specific of type of eating disorder (e.g., anorexia nervosa (AN),
bulimia nervosa (BN), or eating disorder not otherwise specified (EDNOS)). In contrast,
unidimensional measures are designed to assess one or a few specific symptoms of eating
disorders and tend to be continuous measures, although cutpoints are occasionally established to
indicate when a score falls in a categorical clinical versus non-clinical range. The following will
examine these two types of measures used for assessing change in eating disorder
symptomatology. The uses and limitations of each type of measure for tracking symptoms and
assessing recovery will also be explicated.
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Diagnostic measures. Both interviewer-based and self-report measures have been
developed to assess the presence or absence of eating disorders.
Interview based diagnostic measures. Some eating disorder symptoms are considered to
be complex and/or ambiguous. Concerns that self-report instruments may not be capable of
adequately assessing eating disorder symptoms led to the development of the interview
diagnostic format (Cooper & Fairburn, 1987). For example, it was assumed that individuals
completing a self-report diagnostic instrument may have an arbitrary definition of some
symptoms, such as binge eating or restrictive eating, and those definitions would qualitatively
vary among individuals. It was also assumed that the severity of symptoms might be difficult to
determine by respondents. Thus, interview-based diagnostic measures, in which a trained
individual interviews respondents and then rates their responses based on operationalized
criteria, were developed to enable more standardized symptom assessment. This class of
diagnostic instruments has considerable inter-rater reliability, ranging between .75 and .99, and
convergent and discriminant validities in the moderate ranges (Clinton & Norring, 1999; Cooper
& Fairburn, 1987; Fairburn & Cooper, 1993; Gharderi & Scott, 2002; Rizvi, Peterson, Crow, &
Agras, 2000; Rosen, Vara, Wednt, & Leitenberg, 1990; Sysko, Walsh, & Fairburn, 2005).
Of the interview-based assessments, the most widely used and researched is the Eating
Disorder Examination (EDE). The EDE is semi-structured in format, typically requires nearly an
hour to administer, and has undergone several revisions (Guest, 2000, Cooper & Fairburn, 1987,
Fairburn & Cooper, 1993). It is designed to be sensitive to the presence or absence of an eating
disorder, assessing the occurrence of symptoms on 28-day intervals, consistent with current
diagnostic criteria for defining the presence of an eating disorder (Sysko, et al., 2005). Several
other instruments have been designed for the similar purpose of diagnosing eating disorders,
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including the Rating of Anorexia and Bulimia interview (RAB; Clinton & Norring, 1999) and
the Interview for Diagnosis of Eating Disorders (IDED-IV; Kutlesic, Williamson, Gleaves, et al.,
1998). These measures have also been shown to be reliable and valid measures of diagnosis,
although not as comprehensively empirically evaluated as is the EDE.
Despite the strengths of these diagnostic interviews in detecting the presence or absence
of eating disorders and their use as reliable outcome measures, they are ill suited for assessing
change during the course of treatment. One primary reason is that diagnostic interviews are not
temporally sensitive. The interview format categorically assesses symptoms of eating disorders
in long time intervals, which prevents clinicians from tracking symptoms on a weekly basis
(Binford, Le Grange, & Jellar, 2005). For example, the EDE, as previously noted, by design
inquires about 28-day intervals. Furthermore, while interviewer-based diagnostic instruments, of
which the EDE is the gold-standard for assessing eating disorders, are valid and reliable
measures of presence or absence of specific categories of eating disorders, they are time and
labor intensive, requiring specialized training to administer and are not feasible to administer on
a repeated basis during treatment due the lack of brevity of the assessment.
The use of a nominal level of symptom analysis, typical of interviewer-based diagnostic
measures, does not allow for measurement of incremental individual progress or change. The
EDE, for example, focuses and is more concerned with detecting the presence or absence of an
eating disorder rather than the severity of the eating disorder or specific symptoms displaying
elevations. When tracking symptom change during treatment, information on the changes in
specific symptoms is of particular interest. Clinicians can use this information to inform
treatment, such as tailoring treatment, by assessing which symptoms are elevated. While
diagnosis as a criterion for outcome indicates whether an individual has a diagnosable level of an
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eating disorder, it cannot inform a clinician if an individual is improving beyond the presence or
absence of a disorder or on specific dimensions of eating disorder symptoms. Categoricallybased diagnostic information is useful in ascertaining the extent to which the presence of an
eating disorder exists, but this information does not help a clinician on the symptom level, nor
can this be done on a session-by-session basis using diagnostic measures.
Also problematic for current diagnostic instruments for eating disorders is the EDNOS
diagnosis found in the DSM-IV-TR (APA, 2000). Most diagnostic measures do not distinguish
very well between subthreshold eating disorders and the absence of an eating disorder diagnosis
(Mitnz, et al., 1997; Vetrone, Cuzzolaro, Antonozzi, & Garfinkel, 2006). Those persons who do
not quite meet the diagnostic criteria for AN or BN but are displaying some clinically significant
eating and/or body image symptoms are aggregated in the EDNOS category, yet this category
has no specific definition and vague criteria for inclusion. Furthermore, change in this category
is particularly difficult to ascertain using categorical measures since individuals can change
significantly on some symptoms yet still meet criteria for EDNOS based on other symptom sets.
Categorical measures can also miss significant symptoms in those who may recover categorically
from AN or BN. For example, an individual who at pretreatment met the diagnosis of anorexia
or bulimia and improves in therapy and no longer meets the full diagnostic criteria for an eating
disorder may continue to show significant symptoms and signs of eating disorders and
impairment, yet be considered recovered based on categorical diagnostic measures.
Consequently, utilizing a categorical diagnostic measure as an assessment of outcome with the
EDNOS and subthreshold diagnoses is problematic.
Given the vagueness of the criteria used for diagnosing EDNOS, few if any current
diagnostic measures even classify EDNOS. The method of how recovery is defined for EDNOS
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has also not been developed. The EDNOS diagnosis is considered to be severe in
symptomatology and psychological dysfunction (Nollett & Button, 2005), yet is often considered
a less severe eating disorder despite being a viable diagnosis indicating no significant differences
from other eating disorders on various measures of impairment in functioning (le Grange,
Binford, Peterson, et al., 2006). The EDNOS diagnosis is the most commonly diagnosed
category of eating disorders, is severe and persistent, and should not be merely considered a
subthreshold of AN or BN (Crow, Agras, Halmi, et al., 2002). Recent work also suggests that
there are fundamentally different characteristics between AN, BN, and EDNOS (Fairburn,
Cooper, Bohn, et al., 2007). There was no significant difference in the “restraint” subscales
between groups, indicating similarities, while differences were found in body mass index (BMI),
preoccupation with food, and fear of losing control. Significant differences were found in
relation to “importance of shape,” “fear of weight gain,” and “desire to lose weight,” signifying
that EDNOS is not just a mild or subthreshold form of anorexia or bulimia (Turner & BryantWaugh, 2004). The difficulty of operationalizing the EDNOS diagnostic category by current
categorical diagnostic measures suggests the potential utility of measures using a more
dimensional approach, rather than categorical, to assessing eating disorder symptoms.
By design, diagnostic instruments are not constructed to be used as symptom tracking and
change measures. When used to track symptom change and determining outcome, which
extends beyond the construct validity of such measures, the definitions of recovery (or sufficient
change) are inconsistent. Keel, Mitchell, Davis, Fieselman, and Crow (1999) conducted a metaanalysis examining definitions and predictions of eating disorder recovery and found varying
definitions. One study defined recovery as 9 consecutive weeks without eating disorder
symptoms while another study used 12-month criteria. There was no statistical or clinically
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significant index that an individual would be required to meet to be considered recovered.
Without such a change index, it is difficult to determine if a client is “on track” in regard to
progress during treatment, to determine prognosis given response patterns, or to determine if and
when treatment should be modified or ended. Consequently, clinicians are unable to address
whether the symptoms a patient is experiencing are improving even when meeting criteria for an
eating disorder as there are no psychometric indices to determine if changes in severity of
symptoms are significant. Current diagnostic measures lack psychometric change indices for a
clinician to utilize to interpret change scores, which limits their use in tracking eating disorder
symptoms or determining if individuals are approaching recovery.
In sum, the interview-based, diagnostic measures are inherently limited in assessing
change in eating disorder symptoms. Though comprehensive interview-based diagnostic
measures assess the spectrum of eating disorder symptoms and can be utilized as a diagnostic
criteria-based outcome measure, they cannot be used at each session as they are not designed in
this manner due to time and resource limitations. Interview diagnostic measures are able to
discriminate well between individuals with and without a diagnosis of an eating disorder and
determine outcome categorically, but the presence of qualitative changes in symptoms are not
examined (Jarman & Walsh, 1999) and no valid psychometric indices of change are used.
Self-report based diagnostic measures. The need for easily administered assessment of
eating disorder diagnoses resulted in the emergence of several self-report eating disorder
assessment instruments, such as the Eating Disorder Inventory (EDI; Cumella, 2006), Eating
Disorder Evaluation Questionnaire (EDE-Q; Mond, Hay, Rodgers, & Owen, 2006; Peterson,
Crosby, Wonderlich, et al., 2007; Sysko et al., 2005), Bulimia Test-Revised (BULIT-R;
McCarthy, Simmons, Smith, et al., 2002), Eating Disorder Diagnostic Scale (EDDS; Stice,
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Telch, & Rizvi, 2000), Questionnaire for Eating Disorder diagnosis (Q-EDD; Mintz et al., 1997),
and Eating Attitude Test 40 (EAT-40; Mintz & O’Halloran, 2000). Most of these instruments
have high internal consistencies, and convergent validity with interview format diagnostic
measures. Studies of these measures have indicated coefficient alpha reliabilities of .90 for full
scales (Bennett, 1997; Clinton & Norring, 1999; Cooley & Toray, 2001; Eberenze & Gleaves,
1994; Peterson, Crosby, Wonderlich, et al., 2007; Reas, Grilo, & Masheb, 2006) and also high
construct validity (Espelage, Mazzeo, Aggen, et al., 2003). The Gharderi Survey for Eating
Disorders (G-SEDS) also emerged with high positive predictive value with the EDE, concurrent
and discriminant validity with the EDI, and high test-retest reliability, meeting the need for an
“easily administered and cost-effective instrument for screening and establishing the diagnoses
of eating disorders” (Gharderi & Scott, 2002, pg. 61).
The two most commonly used self-report diagnostic measures are the EDI and EDE-Q.
The EDI’s internal structure consists of eight factors, such as bulimia, drive for thinness, and
perfectionism, similar to the factor structure of the EDE (Kordy, Percevic, & Martinovich, 2001).
These self-report diagnostic measures were initially criticized for their inability to objectively
assess binges, though comparisons of objectively and subjectively assessed binges indicated no
significant differences in symptoms of psychopathology (Pratt, Niego, & Agras, 1998). There
were no significant differences found between the two types of assessment of binges on
measures of BMI, restriction, and psychological functioning, supporting the utility of the selfreport format and assessment of subjective binges. The EDI is now in its third revision. The
latest version includes 91 items, 12 scales, 6 composite scores, and 3 response style or profile
validity indicators (Cumella, 2006). As with the interviewer-based measures, the EDI-3 is
designed for use as a measure of diagnostic status. The EDE-Q is the shortened self-report
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questionnaire of the EDE, which has concurrent validity with the EDE (Binford, et al., 2005),
though showing some discrepant results on factors such as binge eating and shape concerns.
Despite these discrepancies between the interview and self-report versions of the EDE, the
concurrent and discriminant validities are not greatly affected.
Though several self-report diagnostic measures have high reliabilities and convergent
validities, there are several limitations of these measures. For example, measures such as the
EAT-40 have been shown to have high false-negative diagnoses for EDNOS (Mintz &
O’Halloran, 2000). This category of measures also does not address several aspects of eating
disorders included in the EDE, such as dietary restriction, binge eating, and vomiting. The EDI2 was further shown to have scales that did not contain discriminant validity between BN
patients and the general psychiatric population (Schoemaker, Verbraak, Breteler, & Van Der
Staak, 2003).
Moreover, the use of self-report diagnostic measures for tracking symptom change and
outcome is problematic for various reasons. Mintz et al. (1997) examined existing self-report
diagnostic measures. The authors examined two types of self-report diagnostic measures—preexisting inventories and questionnaires designed de novo for specific studies. The use of such
measures for tracking of symptoms was criticized for various reasons. First, the examination
revealed that many of the self-report diagnostic measures were outdated and based on the
Diagnostic and Statistical Manual third revision (DSM-III). Second, the measures often did not
capture all of the eating disorders and generally only assessed one eating disorder, such as AN,
excluding BN and EDNOS diagnoses. Measures designed to assess BN also identified those
with AN and EDNOS diagnoses as having BN, supporting evidence that a dimensional approach
to eating disorders is needed as many symptoms overlap between eating disorders (Tylka &
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Subich, 1999). Further, Mintz, et al., (1997) found that if a measure did assess more than one
eating disorder, the differential diagnoses were occasionally inadequately reliable, such as the
EAT-40 had high false positives for AN. Third, the de novo measures did not indicate
generalizability across studies as many measures were only used once. The development of
many of the operationalized criteria of eating disorder diagnoses in the de novo measures were
also not well laid out or explained, contributing to the decreased generalizability. Finally, many
de novo measures had arbitrary decision rules used to arrive at diagnoses. These variable
decision rules applied to criterion variables such as binge eating, which were not accurate
operationalizations of DSM criteria and were inconsistent.
There are several additional methodological flaws when using self-report diagnostic
measures for symptom tracking. Logistically, these measures are administered over longer time
intervals and not on a session-by-session basis. Though more brief than the interview format
diagnostic measures, most self-report measures also still require approximately 20 to 30 minutes
to complete, which can vary with greater severity of symptoms. Thus, it is impractical to
administer such measures on a session-by-session basis and change cannot be assessed in the
midst of treatment. More importantly, like the interview format, self-report diagnostic measures
are used for assessing the presence or absence of an eating disorder. The self-report measures
also do not provide the sort of specific information about specific dimensions of eating disorder
symptomatology at each session, such as the amount of body dissatisfaction an individual
experiences or the frequency of body checking, that would be useful for a clinician to know
during therapy.
Overall, despite the availability of fairly brief, valid, and reliable self-report diagnostic
measures, specific measures of eating disorder symptom tracking are not available. There are
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weaknesses with diagnostic instruments, interview and self-report, but they are generally reliable
and valid measures of the presence or absence of eating disorders and determining outcome
based upon diagnostic status. However, despite which diagnostic measure is used, diagnostic
instruments are not designed nor intended to be administered on a session-by-session basis and
do not provide indices which could: (a) indicate progress during treatment (or lack thereof), (b)
provide detailed feedback about client severity on particular dimensions of eating disorder
symptomatology, nor (c) provide information as to when the client is no longer in a clinical
range on the measure during treatment.
Unidimensional, domain-specific measures. A number of self-report measures have
been developed to assess the presence and severity of specific dimensions of eating disorder
pathology. These include measures such as the Beliefs About Appearance Scale (BAAS;
Spangler & Stice, 2001); Body Checking Questionnaire (BCQ; Calugi & Grave, 2006), Body
Parts Satisfaction Scale (BPSC; Petrie, Tripp, & Harvey, 2002), Body Image Avoidance
Questionnaire (BIAQ; Rosen, Srebnik, Saltzberg, & Wendt, 1991), Dieting Beliefs Scale (DBS;
Stotland & Zuroff, 1990), Goldfarb Fear of Fat Scale (GFFS; Goldfarb, Dykens, & Gerrand,
1985), Three-Factor Eating Questionnaire (TFEQ; Stunkard & Messick, 1985), Fear of Gaining
Weight (FGW; Rushford, 2006), Body Uneasiness Test (BUT; Cuzzolaro, Vetrone, Marano, &
Garfinkel, 2006), and Testable Assumptions Questionnaire-Eating Disorders (TAQ-ED;
Hinrichsen, Garry, & Waller, 2006). These measures have adequate to good test-retest reliability
ranging from .69 to .90 and internal consistencies between .69 and .92.
Self-report measures attempt to assess one or a very few specific aspects of eating
disorders singly, such as the single constructs of binge eating, food restriction, body
dissatisfaction, body checking, or body avoidance. The BIAQ, for example, attempts to assess
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only body image avoidance, or how individuals avoid viewing their own bodies. Rosen et al.
(1990) stated that clinical diagnostic interviews such as the EDE, though longer, have superior
breadth, depth, objectivity, and favorable psychometric characteristics than unidimensional
measures of eating disorders. Comparing the BET, BSQ, and BIAQ, there was only moderate
concurrent validity with measures of dietary restraint and overeating from eating records and
several behavioral measures. Compared to the EDE, these measures were not indicated to add
discriminant validity (Rosen, et al., 1990).
These domain-specific measures are often found to reliably distinguish between controls
and eating disorder patients, and many of them are brief enough to be administered on a sessionby-session basis. However, few criteria have been developed to establish clinically significant
change on such measures, nor do they assess a comprehensive range of eating disorder
symptomatology (Ametller, Castro, Serrano, et al., 2005; Benninghove, Jurgens, Mohr, et al.,
2006; Rodriquez-Cano & Beato-Fernandex, 2005) and are therefore limited in scope.
Adequately assessing change in eating disorder symptomatology would therefore require
administering a number of such measures simultaneously, requiring a significant time
commitment that would be unwieldy on a session-by-session basis. Lack of psychometric
change indices for these measures also results in limited ability to judge whether or not
significant change is occurring.
Existing eating disorder treatment tracking measures. There are currently two
published measures which are designed to be used on a session-by-session basis to assess eating
disorder symptom change in patients, namely the Multiaxial Assessment of Eating Disorders
Symptoms (MAEDS; Anderson, Williamson, Duchmann, Gleaves, & Barbin, 1999; Martin,
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Williamson, & Thaw, 2000) and Short Evaluation of Eating Disorders (SEED; Bauer, Winn,
Schmidt, & Kordy, 2005).
The MAEDS is a 56-item, self-report measure for the assessment of eating disorder
symptoms. It assesses six factors associated with eating disorders: binge eating, purgative
behavior, avoidance of forbidden foods, restrictive eating, fear of fatness, and depression. The
internal consistencies for the MAEDS subscales range between .80 and .92. The MAEDS
purports that it is able to assess and screen for the presence and severity of eating disorder
symptoms, as well as to be used for differentially diagnosing eating disorders as particular
patterns of subscale scores are associated with specific eating disorders. Further, it is used to
assess treatment progress (Martin, et al., 2000). The MAEDS is intended to specifically assess
eating disorder symptoms, but does not contain items to comprehensively assess the eating
disorder spectrum. The MAEDS does not include relevant eating disorder symptoms such as
body checking and. Additionally, the authors of the MAEDS acknowledged there are overlaps
between factors which may be assessing similar rather than distinct features of eating disorders,
such as restrictive eating and avoidance of forbidden foods. The MAEDS also includes factors
not directly relevant to eating disorders. For example, while depression is at times comorbid
with an eating disorder and is sufficiently common that the inclusion of such a factor may be
useful, it is not a recognized feature of eating disorder symptomatology, yet depression is one of
the six main factors on the MAEDS and accounts for 11.1% of the variance of the MAEDS
(Anderson et al., 2000). Further, the MAEDS does not provide psychometric indices that would
indicate clinically significant change nor linear models to aid in projecting recovery.
The SEED was developed as a very brief, monitoring measure of treatment progress
(Bauer, et al., 2005) and contains only six items. The six questions assess weight and height, the
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degree to which an individual fears becoming fat or gaining weight, how they perceive their
body, the frequency of purging behaviors, if amenorrhea is experienced, and ascertaining birth
control pill consumption. The SEED was intended to be sensitive to change in eating disorder
symptomatology (Bauer et al., 2005), though is designed to assess some symptoms, such as
binge eating, over a four week period, rather than weekly. The SEED is also indicated to have
weak construct validity as it only correlated between .25 and .40 with the EDI for BN and AN
subjects, respectively. Concurrent reliability of clinician and patient ratings ranged from .19 to
.78 for items on the SEED. It is also unclear how the questions were developed and the rationale
for assessing limited domains was not given. For instance, no information on the amount of
restriction is provided from the limited questions, nor areas assessing the degree to which
individuals are engaging in body checking behaviors or the extent of binge eating. In general,
the SEED does not provide enough specific information about symptoms of eating disorders.
Symptom tracking measures have limited utility if specific information on symptomatology is
not available and clinicians are not given a comprehensive understanding of the degree to which
individuals are experiencing various symptoms and if any change is observed.
The MAEDS and SEED are quickly administered tracking tools that can be used on a
session-by-session basis. These instruments are a starting point for tracking symptom change,
though they have problematic areas. Both are not adequately comprehensive in their assessment
of eating disorder symptoms. One of the most pressing limits, which have not been addressed
for tracking tools, is the lack of utilization of psychometric indices of change. These existing
tracking measures that have been developed to be given on a session-by-session basis in eating
disorders have not provided empirically supported psychometric indices which would signify
change and relation to a functional or more functional population. Without psychometric indices
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for eating disorder tracking tools, there are no evidence-based options for clinicians to apply in
daily practice. An inferential statistic is needed that estimates the magnitude of change in a score
necessary for a change score to be considered statistically reliable. Cut points which
differentiate membership between two or more populations would also be useful indicators for
use in treatment decisions, which led to the development of the Changes in Eating Disorder
Symptoms Scale. The internal and temporal reliability of the CHEDS and its construct validity
have been recently demonstrated (Spangler, 2010). However, there remains a need to establish
psychometric change indices and trajectory analysis for the CHEDS.
Assessment of Symptom Change in Eating Disorders
The need for a psychometrically sound tracking and outcome measurement tool that is
both concise enough to be given at each session and comprehensive, assessing the range of
eating disorder symptoms and features, is important in assessing the occurrence of change in
individuals with eating disorders to inform and aid clinicians in treatment decision making.
Brown, Burlingame, Lambert, et al. (2001) state that “outcome measurement involves assessing
the clinical outcome of treatment through the use of standardized measures of clinical severity”
(p. 925). Further, Brown et al. add that “outcome management is an effort to improve the
effectiveness of treatment services…by evaluating outcomes data” (p. 925). This indicates a
need for “continuous monitoring of patient progress [which] has been recognized as a core
component of evidence based treatment” (Burlingame, Hwang, Lee, et al., in progress, p. 3).
Without a validated measure of change in the eating disorder literature, clinicians were unable to
reliably assess treatment progress (or lack thereof). Further, tailoring treatment interventions for
those without adequate progress or determining decisions concerning termination or proper
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treatment setting placement for individuals approaching recovery is currently not based on
empirically derived indices for those with eating disorders.
Weekly assessment of patient progress accompanied by the use of clinical significance
markers to aid in the calibration of treatment decision processes has been advocated by several
researchers (e.g., Burns, 1995; Jacobson & Truax, 1991; Lambert, Okiishi, Finch & Johnson,
1998). A dimensional measure of main features of the entire eating disorder spectrum
circumvents the problems of diagnostic categorizing of individuals, such that all persons with
eating disorder spectrum disorders can be tracked during treatment and evaluated on severity of
major dimensions of eating disorder symptomatology. With specific feedback for clinicians on
major dimensions of symptoms of eating disorders, relevant and meaningful information can be
used to assess intervention effectiveness, future planning, and current functioning.
The eating disorder literature is mature and advanced with regard to diagnosis and
treatment content. The next step in eating disorder assessment is to develop a measure that is
comprehensive and brief, while being reliable, valid, and sensitive to change and possessing
empirically derived change indices. The Changes in Eating Disorder Symptoms Scale (CHEDS;
Spangler, 2010) is a tracking and outcome measure of eating disorder symptomatology with
breadth, brevity, and high reliability and construct validity. The content domains for the CHEDS
were derived utilizing eating disorder diagnostic measures, DSM-IV diagnostic criteria, existing
measures related to eating disorder symptomatology, clinical experience, and the theoretical
literature regarding the primary dimensions of eating disorder symptoms. The CHEDS loads
significantly onto seven factors, which accounts for 73% of the variance. Only two of the 35
items load onto more than one factor; these two items were retained as they loaded more onto
one factor over the other both theoretically and quantitatively. Intercorrelations among the
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factors were in the low to moderate ranges (range .09 to .43). The CHEDS also has strong
discriminant validity, being able to discriminate between eating disordered and non-eating
disordered groups with a sensitivity and specificity of 80%. The CHEDS was compared to
several full-scale unidimensional measures which were expected to be differentially related to
the CHEDS subscales and demonstrated expected correlational patterns with such
unidimensional measures. Although there is strong support for the psychometric properties of
the CHEDS, it lacks psychometric change indices such as empirically-derived reliable change
indices, cutscores, and hierarchical linear modeling (HLM) benchmarked trajectories to allow for
the determination of clinically significant change during treatment and to provide an index of
recovery.
Clinical Significance
Utilizing evidence-based change indices, as opposed to qualitative judgments, is vital in
assessing change (Wise, 2004). Current instruments assessing eating disorders, whether
diagnostic or dimensional, do not provide psychometric indices to define and judge whether
reliable and clinically significant change has occurred. Clinical significance refers to meeting
the standards of efficacy set by consumers, clinicians, and researchers (Jacobson & Truax, 1991).
In some cases, these standards are set as changing one, two, or three standard deviations on a
measure (Jacobson, Follette, & Revenstorf, 1984). In recent literature, the criteria which should
be used for clinical significance has been actively debated. For example, debates have focused
on what the appropriate magnitude of standard deviation a patient has to change on a measure to
be considered to show clinically significant change, and on the use of normative cutscores
between populations (Wise, 2004; Burlingame, in progress). The importance of determining
clinical significance is first defining what it means for a patient to be recovered. This is to say,
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how much a patient has to change to be considered as moving from a dysfunctional category to a
functional category (Jacobson & Truax, 1991; Wise, 2004).
In the analysis of clinical significance, Jacobson et al. (1984) addressed whether a patient
has changed two standard deviations towards the direction of functionality and whether that
patient’s post-test score falls under a normal population. This suggests that normal distributions
of functional and dysfunctional populations are necessary for comparison to ascertain which
population a patient’s score is indicative of, exhibiting clinically significant change as a patient’s
post-test score is representative of what would be considered a functional or more functional
population (Wise, 2004). Tingey, Lambert, Burlingame, and Hansen (1996a) proposed using
multiple samples in a continuum such as functional and dysfunctional. Recent studies have
begun to utilize multiple relevant samples, such as functional, less functional, and dysfunctional
samples (i.e., community normal, outpatient, and inpatient, respectively; Burlingame, in
progress). When there are no normative samples to compare to, changes of standard deviations
on a measure noted above from pretest to posttest has been used. This method of assessing
clinical significance, though, is problematic as it does not take into consideration measurement
error and uses an arbitrary magnitude of clinically significant change (Wise, 2004).
In contrast, a reliable change index (RCI) and normative cutscores are psychometric
indices that are useful tools to compare an individual’s score on a measure to a respective
population. The RCI indicates a statistically significant value that clinicians and administrators
can use to make empirically based decisions in their assessments of patient progress. A cutscore
is a change index indicating a point in which marks the difference between populations and are
based on specific norms that reflect the typical distress experienced across the spectrum of
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psychiatric populations. For instance, one would assume increasing levels of symptom distresses
as one would move from a functional sample to a less functional, or dysfunctional, sample.
Reliable change index. A RCI is the difference between scores on a measure that a
patient must achieve to be considered to have made a statistically significant change. It also
takes into consideration measurement error (i.e., the more unreliable the measure, the greater
change is required). The formula is as follows:
RCI = (time1 )  (time2 )  Sdiff  1.96(a  .05)
Sdiff =

2S E

2

SE = SD 1  rxx
Alpha levels for the RCI can be tailored to the specific aims of a study or practice. An alpha
level of .05 provides a strict measure of change as the RCI will be a greater value than with a .10
alpha level; subsequently, a patient measured using a strict alpha level will have to show greater
amounts of change or a greater difference score between scores.
Lunnen and Ogles (1998) found the RCI was able to distinguish individuals who
exhibited a positive reliable change but found that the RCI was less effective in differentiating
those who showed no change or deteriorated, or had a negative reliable change. The RCI has
also been criticized by some as not accounting for regression to the mean, or the “phenomenon
observed that if a specific variable is to be predicted from another variable, each of the values
pertaining to the variable which it is predicting (having some distance from its mean),
corresponds with a less extreme (i.e., closer to its mean) predicted value” (Hageman & Arrindell,
1993, pg. 695). Though when an RCI is calculated taking into account measurement error, it
provides a more accurate index than arbitrarily set statistical significant measures. When the
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RCI is calculated with a measure of reliability (rxx), it makes the RCI more stringent. The more
unreliable the assessment, the greater RCI is needed for a subject to exhibit a reliable change.
Cutscores. A normative cutscore is a statistically significant cut off value between two
populations. As previously mentioned, relevant normative populations are needed to identify
how much change a patient must exhibit to be considered to have reliably changed on a measure
while also moving from a dysfunctional to a functional population. Cutscores are calculated
using the following formula:

cutscore

(SD1)(mean2 )  (SD2 )(mean1)
SD1  SD2

SD= standard deviation
The critics of clinical significance indices emphasize that for a patient to exhibit true
change, they must have both a significant difference between their scores and also change from a
dysfunctional to functional population (Wise, 2004). In response, an RCI and cutscores must be
used in conjunction to identify patients who are considered recovered and also to identify
relevant comparative normative populations. These methods have yet to be applied to eating
disorder measures, though would add significantly to the utility of measures in assessing client
change.
Eating disorder clinical significance testing. A relatively recent meta-analysis assessed
clinically significant change in eating disorder symptoms in various studies of cognitivebehavioral therapy (CBT) efficacy, utilizing the RCI and equivalency testing for group level
analysis. The study indicated that CBT for eating disorder yields clinically significant change as
assessed by the EDE (Lundgren, Dannoff-Burg, & Anderson, 2004). This analysis of clinical
significance used a diagnostic measure on an aggregate level, providing support for the efficacies
of treatment on the group level by comparing the means of diagnostic criteria items (e.g.,
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frequency of binge eating) among various studies at pre and post intervention. Though this study
provided relevant feedback on the aggregate level, outcome was defined using diagnostic criteria
comparing group means, which does not provide utility in assessing individual change or the
ability track change in patients during treatment. The meta-analysis did not utilize an RCI using
a comprehensive assessment of eating disorder symptoms as reliable change was only assessed
on binge and purge frequencies in a given week. Clinically significant change as defined by
Lundgren, et al. (2004) was primarily based on the dichotomous method of meeting an eating
disorder diagnosis, despite a reliable change on specific dimensions of binge eating and purging
frequencies. There was also no evidence that clients were more representative of a functional
population by utilizing normative cutscores on the dimensional measures, though diagnostic
criteria for the EDE was used.
The EDE-Q was examined in a study by Sysko et al. (2005) as a diagnostic outcome
measure. This outcome, though, was only defined as achieving concurrent validities of pre and
post treatment assessment of diagnosis compared to the EDE. Though the use of a pre and post
treatment diagnosis using the self-report diagnostic measures can show change in an individual,
it goes beyond its intended measure, is not time-sensitive, and does not indicate the amount of
change needed from pre and post scores to be considered clinically significantly changed. There
have also been uses of statistically significant change in studies of eating disorders, such as
changes of standard deviation on an eating disorder measure or effect sizes (Safer, Agras, Lowe,
& Bryson, 2004). Criteria of eating disorder outcome using statistical significance are
problematic as they do not indicate if an individual actually experiences clinically significant
change. Utilizing solely a statistically significant change criterion does not give enough
information supporting change, as it is an arbitrary statistical criterion based on a percentage of
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change (e.g., standard deviation). This method does not account for extraneous variables such as
error in the measure. Using statistical criteria for clinically significant change does not account
for low reliability of a measure, or the degree of confidence of the probability of clinically
significant change (such as a reliability of .95 or .90).
Change trajectory analyses. There are some proposed predictors of change in eating
disorder treatment using various measures in the eating disorder research (Satandar-Pinnock,
Woodside, Carter, et al., 2003; Miller, Schmidt, Vaillancourt, et al., 2006; Peake, Limbert, &
Whitehead, 2005; Wonderlich, Crosby, Joiner, et al., 2005), but the only consistently empirically
supported predictor of outcome is initial severity of symptoms and early changes in binge eating
and purging symptoms (Halmi, Agras, Crow, et al., 2005; Fairburn, Agras, Walsh, et al., 2004;
Agras, Crow, Halmi, et al. 2000). With the various assessments of predictors of change
providing a breadth of knowledge concerning initial severity scores, there has been no analysis
of trajectory of clinically significant change using a repeated, comprehensive, and
psychometrically sound eating disorder tracking and outcome measure.
Hierarchical linear modeling (HLM) is a method to classify or arrange groups that share
the same qualities, and the relationship in each level can be studied. This method allows for
trajectories of groups of people to be projected with respect to outcome. A linear model that
accounts for variations in each level of initial severity scores on an outcome measure can be
developed. This is possible in using a longitudinal analysis as repeated measurements of
outcome can be nested within levels of initial scores (Laurenceau, Hayes & Feldman, 2007;
Singer & Willett, 2003; Weinfurt, 2000; Harrison & Raudenbush, 2006; Lambert et al., 1998;
Wells, Burlingame, Lambert, et al., 1996). Trajectories of individual client progress can be
developed to determine if patients are exhibiting on-track improvements or off-track
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deteriorations as clinicians utilizing the aforementioned clinically significance criteria can also
use these trajectories. Amalgamating the RCI, cutscores, and HLM trajectories will allow for
empirically based decisions of treatment placement, intervention strategies, and monitoring of
week-to-week progress.
Quality of life assessment. Clinically significant change has also been analyzed through
the assessment of quality of life assessments. Health surveys have been used as indications of
disorders having adversely and significantly interfering or impairing impact with overall life
functioning. While broad measures exist, disorder-specific measures are necessary as general
health related quality of life measures do not capture the intricacies of specific disorders (Engel,
Wittrock, Crosby, et al., 2006). The Eating Disorders Quality of Life (EDQOL) scale was
developed by Engel et al. (2006) and was tested and validated against the Structured Clinical
Interview of DSM. Compared to other health related quality of life questionnaires, it was found
to be more sensitive to change than general quality of life measures. The EDQOL, though, was
not compared with the EDE or any other specific measures of eating disorders.
The Centre for Research on Eating Disorders at Oxford (CREDO) recently developed the
Clinical Impairment Assessment (CIA) as an assessment of the effect of having an eating
disorder on the level of life functioning and quality of life (Bohn, Doll, Cooper, et al., 2008;
Bohn & Fairburn, 2008). The CIA is designed for use in clinical subjects only, as it assesses
how eating disorder symptoms are functionally impairing in major life domains such as
relationships, work, etc. Its goal is to provide “a simple single index of the severity of
psychosocial impairment secondary to eating disorder features” (Bohn & Fairburn, 2008,
appendix iii). These life functioning measures have utility in providing convergent data of
clinical significance, but also can be used to measure eating disorder specific changes in
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functioning that would be able to indicate progress. The CIA can be used as a valid measure of
change in life functioning associated with an eating disorder with a test-retest reliability of .86
(95% CI .75–.92; p < .001) and a construct validity with the EDE-Q of .89 (p < .001; Bohn &
Fairburn, 2008).
Eating Disorder Tracking and Outcome Measure Status
The current use of diagnostic criteria for determining outcome does not provide enough
information on specific symptoms. This definition of outcome is not based on symptom
reduction but a categorical determination of meeting a diagnosis. The spectrum of eating
disorders is wide, and individuals can vary greatly in severity of pathology and in presentation.
Defining recovery should not only assess the key aspects of eating disorders but also track the
changes in symptoms. The subscale structure of a comprehensive measure should assess the
primary dimensions of eating disorder symptoms, operationalized from diagnostic criteria as well
as key features indicated in the literature. These aspects include assessing behavioral
components such as binge eating and purging, as well as psychological domains such as fear of
becoming fat, body dissatisfaction, and preoccupations with food.
It is also preferable to use empirically calibrated methods to assess progress itself in
individuals; without empirically supported psychometric indices, tracking of symptoms becomes
arbitrary. Assessing clinically significant change on an individual basis is needed to determine
progress or lack thereof. Being able to develop trajectories to assess if clients are on or off the
expected trajectory in regards to treatment progress is also useful, but this methodology has yet
to be applied to eating disorder assessment. An eating disorder specific, comprehensive measure
with these indices has not been developed up to this point. Providing change metrics to assess
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clinically significant change while assessing trajectories of progress would provide clinicians
with useful and relevant information to guide treatment decisions.
Specific Aims
This study utilized two datasets: (a) an archival data set of community non-eating
disordered participants, and (b) a data set of clinically diagnosed eating disordered patients
receiving treatment. These two datasets were used to determine change indices of clinical
significance for the CHEDS.
The goal of the study was to develop clinical significance criteria for interpreting eating
disorder symptom change during treatment and determining progress trajectories. An RCI for
CHEDS total and subscales scores was calculated as an indication of an amount of change
needed to be considered reliably changed, while cutscores were used to distinguish between
disordered and non-disordered populations. The trajectory analysis using HLM provide expected
trajectories of change for patients based on initial severity scores in order to tailor treatment as
necessary or to assess projected linearity to clinically significant change (Harrison &
Raudenbush, 2006). These psychometric indices were not only calculated on the total score level
but also the subscale (or subscale) level.
There were five specific aims of the study:
1. Establish normative data for functional and dysfunctional samples for the CHEDS
utilizing the Tingey, Lambert, Burlingame, and Hansen (1996a) method. Compare
the cutscore derived to the existing cutscore derived by Spangler (2010) using ROC
analysis. .
2. Determine a reliable change index to indicate the amount of change necessary for a
subject to be considered reliably changed for total and subscale scores.
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3. Create a series of expected trajectories of patient progress based on initial level of
severity on the total score and subscale level, providing empirically based guidelines
of a subject’s path to clinically significant change, and a separate trajectory analysis
based on initial scores.
4. Determine the relationship between the CIA, a measure of impairment of life
functioning, and the CHEDS to corroborate clinically significant change. It was
hypothesized that individuals exhibiting clinically significant change on the CHEDS
would have greater reductions in life impairment as measured by the CIA.
5. Categorize patient outcome at the end of treatment into level of clinically
significantly change in four categories: recovered (clinically significant change),
reliable improvement, no change, and deterioration.
It was hypothesized that the clinical sample at intake would be significantly higher than
the non-clinical sample on all subscales of the CHEDS. It was also hypothesized that using the
clinically significant change criteria using the RCI and cutscores in the clinical sample would
result in significant differences between pre and post treatment scores on the CHEDS, with more
patients having clinically significant change and reliable improvement than exhibiting no change
or deterioration. It was predicted that very few clinical subjects’ initial CHEDS scores would
fall in the non-clinical range as all subjects were diagnosed with an eating disorder using the
EDE. It was also expected that the clinical subjects’ post-treatment CHEDS score would exhibit
clinically significant change after completion of treatment. It was also anticipated that a
proportion of subjects exhibiting no change or deterioration might also be observed. The
subjects’ change scores from pre and post-treatment on the CIA were expected to correlate with
scores indicating clinically significant change on the CHEDS.

27
Methods
Participants
Participants were drawn from two populations: (a) a community non-eating disordered
group and, (b) an eating disordered group undergoing cognitive-behavioral treatment for their
eating disorder. A power analysis for the clinical sample RCI analysis revealed that for a
moderate effect size (d = .50), a sample size of approximately 50 would be needed for the
clinical or dysfunctional sample, which resulted in a power of .86 at the .05 significance level.
The unequal sample sizes of the clinical and non-clinical samples, 58 and 95, revealed a power
size of .95, also at the .05 significance level, with an effect size estimate of .50. This indicates
that the sample sizes were large enough to ensure adequate power and to be able to compare the
two samples. The power analysis supported that a test of the distinctiveness of the two samples
is possible given the sample sizes. These power indices indicate that with the two sample sizes,
the probabilities of rejecting the null hypotheses, if warranted, are high.
The non-eating disordered sample consisted of 95 participants. Participants were
recruited from universities in Colorado and Utah. Participants were recruited through
informational flyers distributed in their general education courses and voluntarily contacted
experimenters themselves. They scheduled times to meet with experimenters where they
consented to participate and were paid $15.00 upon completion of the questionnaires. The
control sample was composed of participants who were 80% Caucasian, 9% Asian, 5% Hispanic,
1% Native American, and 5% who described their ethnicity as “other.” Age ranged from 18 to 46
(M = 22.4, SD = 4.6). The non-clinical subjects signed an informed consent for participation in
the study and could receive extra credit if they were recruited from an undergraduate course.
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The eating disordered sample was recruited through fliers, newspaper ads, and referrals to
an outpatient mental health clinic. The Eating Disorder Examination (EDE; Cooper & Fairburn,
1987; Fairburn & Cooper, 1993) was used to diagnose clients for admission into the study.
Participants were excluded from the study if they had comorbid psychosis, bipolar disorder, a
medical condition that significantly impacts weight (e.g., thyroid conditions), or if they had a
history of bariatric surgery. Participants were not allowed to participate in any other
psychotherapeutic treatment, although concurrent medication use was allowed. All participants
received therapy at no-cost. Fifty-eight eating disordered patients were recruited. The majority
of the participants were female (93%) and Caucasian (98%) with 2% reporting a Hispanic
ethnicity. Age ranged from 18 to 65 (M = 25.24, SD = 9.97). The diagnoses of the clinical
sample primarily consisted of BN and EDNOS, consistent with the literature and prevalence
rates of eating disorders (APA, 2000), and included six subjects with a diagnosis of AN. The
patients signed an informed consent for participation in the study, videotaping for supervision
use, and completion of the measures.
Occasionally items were missing from total or subscale scores due to participants not
completing items. Participants were retained in analyses for the total score analyses if at least
90% of items were completed. For subscale scores, subjects were dropped from the subscale
level analyses if any items were missing. For total scores, five subjects were not used in the
analyses. On the subscale level, three, five, five, four, five, two, and six subjects dropped,
respectively, for the seven subscale analyses.
Treatment
The therapy consisted of cognitive-behavior therapy (CBT) according to the treatment
protocol described by Fairburn (2008). Treatment was of a 40-session duration for patients
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considered underweight (BMI < 17.5), and 20 sessions for normal and above normal weight
(approximating anorexia nervosa versus bulimia nervosa and EDNOS). The therapists in the
study were Ph.D. candidates in clinical psychology. The therapists received training prior to
beginning treatment with study patients, including seeing pilot patients until competency in
delivering the treatment protocol was reached. Therapists also received weekly supervision with
videotaped session review and completed fidelity checks with the treatment protocol at each
session. Each session in the treatment protocol had a specified agenda with assessments and
clinical forms to be used. At session 7, the subject’s progress was examined and barriers to
change were identified to tailor their treatment plan accordingly. While the treatment protocol
was manualized with session-by-session agendas and goals, crucial elements of CBT such as
tailoring for specificity of patients’ symptoms and flexibility to adapt to barriers to change were
included.
Measures
Before each session, the clinical sample was administered all measures by clinic
receptionists. The patients arrived early before each therapy session and completed the
appropriate measures in the lobby area and then returned them to the receptionists. The results
of these measures were not utilized by the therapists and were not used to guide and direct
treatment; the results were also not shared with the clients. Only members of the research team
were permitted access to the results of these measures.
Eating disorder symptoms. The CHEDS was administered at each session for the
clinical group and at a single time point for the non-clinical group. As described in Spangler
(2010), CHEDS items were generated using several methods and then analyzed with respect to
item discrimination (Wilks’ Lambda), item reliability, and endorsement patterns. The CHEDS
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consists of 35 items indicated to have high discriminant ability between eating disordered and
non-eating disordered groups. The CHEDS scale is composed of seven subscales. The subscales
of the CHEDS are: eating concerns/preoccupation, restriction, body preoccupation, body
dissatisfaction, body checking, vomiting, and binge eating (Spangler, 2010). The seven
subscales accounted for 72% of the variance. The reliability coefficients of the subscales range
from .85 to .93, with the exception of one subscale at .73, while the overall internal reliability
coefficient alpha was .96. The subscale with the lowest internal reliability, vomiting, only
contained two items.
The construct validity of the CHEDS was also confirmed as the subscales correlated in
expected patterns with other measures. Means comparisons between non-eating disordered and
eating disordered groups also significantly differed in expected patterns (Spangler, 2010).
CHEDS items are also sensitive to change as the items change in the theoretically proposed
direction during treatment, which is indicated as a useful analysis in measure development
(Vermeersch, et al., 2000; Burlingame, Seaman, Johnson, et al., 2006). CHEDS scores have also
been shown to be significantly higher in eating disordered versus non-ED groups (Spangler,
2010), signifying that the clinical and community sample groups are significantly different. The
ROC analysis yielded a cutscore of 60.
Eating disorder diagnosis. The eating disordered sample was diagnosed using the
Eating Disorder Examination, an interviewer-based diagnostic interview (Cooper & Fairburn,
1987). The interrater reliability coefficients for the five subscales of the EDE range from .83 to
.99 (Rosen et al., 1990). The internal consistency coefficients ranged from .67 to .90 and the
discriminant and concurrent validities are high (Guest, 2000). The control sample was diagnosed
using the Eating Disorder Diagnostic Scale (EDDS; Stice, Telch, & Rizvi, 2000), a self-report
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diagnostic questionnaire. The sensitivity and specificity of the EDDS are .88 and .98,
respectively (Stice, Fisher, & Martinez, 2004). The internal consistency of the EDDS yields a
Cronbach’s alpha of .89.
The eating disordered patients were assessed with the EDE at two time points, treatment
intake and post-treatment. The non-clinical participants completed the EDDS once; at the same
time they completed the CHEDS. Undergraduate-level research assistants who were trained by a
licensed PhD clinical psychologist administered the EDE interviews. Fidelity checks of the EDE
interviews were achieved through audiotape feedback of interview sessions.
Quality of life. The Clinical Impairment Assessment (CIA) was used to assess the extent
to which eating disorder symptoms affect the clients’ level of life functioning (Bohn & Fairburn,
2008) and was administered to the clinical sample only. The CIA was used as a supplemental
indication of clinical significance by assessing level of functioning and obtaining concurrent
validity of clinically significant change on the CHEDS from pre-treatment to post-treatment.
The CIA was administered at intake, mid-treatment (session 7), and post-treatment. The
psychometric properties of the CIA are strong, with test-retest reliability of .86 and a concurrent
validity with the EDE-Q of .89 (Bohn, et al., 2008).
Data Analyses
Reliable change index. Reliable change index (RCI) values were derived for the
CHEDS on the total and subscale score levels. The original formula proposed by Jacobson,
Follette, and Revenstorf (1984) has been criticized as only taking into consideration inherent
measurement error, not a true pre-test score (Wise, 2005). Jacobson and Truax (1991) and
Tingey et al. (1996a, 1996b) proposed use of Sdiff for the measurement of standard error (SE) to
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reflect the amount of difference one could expect between scores (Wise, 2004). This would
make the RCI more accurate in assessing between repeated scores. The formula is as follows:
RCI = (time1 )  (time2 )  Sdiff  1.96(a  .05)
Sdiff =

2S E

2

SE = SD 1  rxx
An RCI was derived for various alpha levels for the total CHEDS score, as well as for the
seven subscales of the CHEDS. In this study, the standard error of measure (SE) was computed
using the internal reliability coefficient of the CHEDS. The SE for the total score was computed
using the clinical and non-clinical samples and a pooled standard deviation value (SD). The
resulting SE value was inserted into the standard error of difference formula (Sdiff). This value
was multiplied by the z-value of the significance level desired, such as 1.96 (p < 0.05). The
resulting value represented the size of the difference needed to achieve reliably significant
change given the error of the instrument and the standard deviations of the eating disordered and
non eating-disordered samples. Change indices for the seven subscales of the CHEDS were also
computed to enable evaluation of change on a subscale level. The CHEDS-RCI scores were also
calculated with different alpha levels (p < .05 & .10) for total and subscale scores to provide for a
range of confidence intervals.
Cutscores. A cutscore refers to a statistically derived point that divides the scores of two
groups that have been created in reference to some criterion. It is a cutoff between adjacent
samples which defines the point where it is statistically more likely for a score to be in one
population as opposed to the adjacent overlapping distribution (Tingey, Lambert, Burlingame, &
Hansen, 1996a; Jacobson & Truax, 1991). In the context of this study, the CHEDS is a measure
designed for a clinical population and as such, the cutscore is the cutoff value on the CHEDS of
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an individual suffering from an eating disorder that moves from a less functional to more
functional. When representative scores for each population have been formed and there is a
statistically and clinically meaningful difference between the populations, a cutscore can be
established that separates the populations from one another (See Figure 1).

Figure 1. Normal Sample Distribution (example). Illustration of two sample distributions with
means (A & C) and cutscore (B).
This study utilized two samples that are close on the continuum of dysfunction. The noneating disordered community sample and the outpatient sample utilized in this study are closer in
comparison than a community normal and an inpatient sample, and thus are expected to be closer
bimodal distributions. Using samples that are close in level of dysfunction allows a clear
explication of the differences between these two populations. It was hypothesized that there
would be overlap between the samples used in this study but a statistically significant difference
indicated by the normative data analysis aforementioned. A psychometric calculation used by
Tingey, Lambert, Burlingame, and Hansen (1996a) was employed to determine the clinical
significance cutscore for the CHEDS. The two sample distributions were used to establish the
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cutscores. Cutscores were calculated between non-clinical and clinical samples. The following
formula was used to calculate the normative cutscores:

cutscore

(SD1)(mean2 )  (SD2 )(mean1)
SD1  SD2

Spangler (2010) determined a cutscore on the total CHEDS scale score using a different method
(i.e., ROC analysis) which indicated a score of 60 to be “the best balance of specificity (i.e.,
percent of those in the ED group who are correctly classified) and sensitivity (i.e., percent of
those in the non-ED group who are correctly classified) … yielding a specificity and sensitivity
of 80% and an AUC of .86” (pg. 136). The ROC cutscore obtained by Spangler (2010) was
compared to the cutscore obtained in this study using an alternate method.
Clinically significant change classification. The RCI and cutscores were applied to the
clinical sample resulting in four categories of change: recovery, reliable improvement, no
change, and deterioration. Recovery is defined as meeting the RCI requirement and crossing the
cutscore into the community normal sample. Reliable improvement is defined as those who have
met the RCI magnitude but did not cross the cutscore. This level of change may contain a small
percentage of individuals who may have fallen under the cutscore at admission. No change is
defined as not meeting the RCI magnitude of change nor crossing the cutscore. Deterioration is
defined as those who met the RCI level in the negative direction. A chi-square analysis of the
frequency of patients classified into these four categories was calculated for CHEDS total scores.
Hierarchical linear modeling. Hierarchical linear modeling (HLM), a multilevel
analysis (Weinfurt, 2000; Harrison & Raudenbush, 2006), was used to assess trajectories based
on the initial level of disturbance for the clinical sample. The main rationale of HLM is to assess
how people change over time and how it is related to other variables. The multilevel analysis
allows variance in outcome variables to be analyzed at multiple hierarchical levels using
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repeated measures data and within-subjects variables. Hierarchical linear modeling is
advantageous as it is a type of mixed model analysis used with hierarchical data to view interindividual variability of change, examining predictors or covariates of interest that will affect the
trajectories, such as initial severity of scores.
The HLM analyses were used to create individual growth trajectories using maximum
likelihood estimation on the CHEDS using an unstructured model. All session-by-session
CHEDS data points available were used in the clinical sample to develop the models. Tukey’s
Ladder of Transformation was used to determine if any time variable transformations of the data
using unconditional growth models was needed. The initial models were decided using theory to
examine the fit statistics (Singer & Willet, 2003). Two log-likelihood (2LL) was examined as a
measure of deviance with each time variable transformation. Essentially, models were created
with variable time transformations, such as natural log, square root, squared, and cubed, to
ascertain which model better matches the shape of the projected paths.
After the shape of the projected paths was ascertained with the least deviance, change
trajectories were generated based on initial scores which would indicate a patient’s projected
path with clinically significant change criteria mapped onto the trajectories. A clinician would
be able to utilize these trajectories to create idiosyncratic paths based on initial CHEDS scores or
strata level. Two main analyses were generated for the trajectories: a path based on initial scores
which a patient followed to achieve clinically significant change, and separate paths according to
classifications of high, moderate, and low severity scores based on divisions of three ranges of
initial CHEDS scores (Lambert, Okiishi, Finch, & Johnson, 1998, Wells, Burlingame, Lambert,
et al., 1996). These analyses were done on the total score levels as well as on the subscale levels.
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The HLM analysis was used to create score bands by stratifying the data according to initial
severity and creating separate models per stratum.
The trajectory models were built starting with all theorized covariates. The main effects
of the intercept, time (sessions), diagnosis (20 session vs. 40 session), and severity strata or
initial score were used in the model as well and interactions between these main effects (e.g.,
session x diagnosis and session x severity strata). The models were built centered on the middle
severity for the strata HLM model and the initial score HLM model was centered on the CHEDS
mean. Each model underwent stepwise deletion of non-significant parameters starting with
deleting the worst significance values (p-values over .05) and then non-significant interactions.
The final models for each analysis then comprised of parameters that yielded all significant
values.
Based on the client’s initial level of disturbance, RCI and cutscore levels were projected
along the HLM trajectory graph so that a clinician could see at any point how a case compares to
the RCI and cutoff points and the various outcome classes (e.g., clinically significant change,
reliable improvement, no change, & deterioration). The clinical significance change metrics
were used along with the upper and lower levels of the trajectories (using a .05 alpha level). The
upper and lower tolerance levels are used like confidence intervals in which a trajectory is likely
to follow. All HLM calculations were computed using the Statistical Package for Social
Sciences (SPSS).
Correlation with life functioning. The CIA was used as a convergent validity measure
of change in life functioning. Correlations were calculated between total scores between the
CHEDS and CIA at pre, mid, and post treatment which provided additional information of

37
clinically significant change. High correlations supported that the CHEDS is related to life
functioning and impairment.
Results
Distribution Analysis
Tests of normal distribution of all data points of the eating disordered sample revealed a normal
distribution using a normality plots test, indicating a Shaprio-Wilk statistic value of larger than .8
(.99, df = 982, p < .01).
Descriptive Statistics
Descriptive statistics (i.e., sample size, range, min, max, mean, and standard deviation)
were compiled for the two samples for CHEDS total and subscale scores (body preoccupation,
body dissatisfaction, body checking, binge eating, restrictive eating, food preoccupation, &
vomit; see Table 1). Mean comparisons indicated that the eating disordered sample was
significantly higher on the total CHEDS score (t (146)= -14.70, p <.01) and all subscales scores
than non-eating disordered groups consistent with previous findings (Spangler, 2010). Chisquared analysis also revealed that the CHEDS is able to discriminate between eating disordered
and non-eating disordered groups (χ2 (1) = 69.08, p < .01).
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Table 1
Community Normal and Clinical Sample CHEDS Total and Subscale Means
Community Normal

Clinical

Subscale

n

M

SD

n

M

SD

t

Body Preoccupation

89

9.39

5.74

55

20.35

5.05

12.13*

Body Dissatisfaction

91

9.55

5.26

53

16.74

2.83

9.28*

Body Checking

93

6.83

4.61

53

12.64

4.18

7.52*

Binge Eating

92

3.36

2.88

54

13.26

6.43

13.00*

Restriction

92

3.23

2.61

53

8.58

4.36

9.34*

Food Preoccupation

94

3.74

3.81

56

14.07

4.13

15.65*

Vomit

94

0.41

0.84

52

2.88

2.37

9.20*

Total

95

37.66

21.48

53

91.02

20.60

14.70*

Note. Clinical scores at session 0. * p < .01.
The CHEDS total score minimums for community normal sample was 4 while the
clinical sample minimum was 38. The maximum score observed for the community normal and
clinical samples were 106 and 139, respectively. This indicated that those in the community
normal sample who did not qualify for a diagnosis of an eating disorder could still display a high
score on the CHEDS. Total score means observed for the two samples were about two pooled
standard deviations (SDp = 21.17) apart at 37.66 and 91.02, for the community normal and
clinical samples, respectively. Subscale level descriptive statistics also yielded proportionately
similar means and standard deviations.
Cutscores
Cutscores were calculated between the two samples on both total and subscale score
levels (Table 2). The total cutscore indicates a CHEDS score that is the cut off between the
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community normal and clinical samples. Comparisons of the total and subscale cutscores and
descriptive statistics of the two samples showed that the cutscores were between the respective
means.
Table 2
Total and Subscale CHEDS Cutscores

Cutscore

% of Patients
Below Cutscore*

9.39

15.22

18%

16.74

9.55

14.22

21%

4.61

12.64

6.83

9.87

23%

6.43

2.88

13.26

3.36

6.41

19%

Restriction

4.36

2.61

8.58

3.23

5.23

28%

Food Preoccupation

4.13

3.81

14.07

3.74

8.69

13%

Vomit

2.37

0.85

2.88

0.41

1.07

33%

20.60 21.48

91.02

37.66

64.89

9%

SD1

SD2

M1

Body Preoccupation

5.05

5.74

20.35

Body Dissatisfaction

2.83

5.26

Body Checking

4.18

Binge Eating

Subscale

Total

M2

Note. SD1 and SD2 are clinical and community normal standard deviations, respectively.
* at session 0 for clinical sample only
The total cutscore created utilizes sample sizes, standard deviations, and means of each
sample to derive the value whereas a ROC analysis assesses true positive rates and false positive
rates, generating a specificity and sensitivity rate. The ROC analysis conducted by Spangler
(2010) identified a cutscore of 60, compared to the cutscore of about 65 in this study.
Reliable Change Indices
The internal consistency coefficient was used for the respective total and subscale RCI
calculations (see Table 3). The total CHEDS internal consistency reliability coefficient is .96
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(Spangler, 2010), which is used for the standard error of difference calculation used in the RCI.
A lower reliability would implicate that a greater improvement would be required to signify
reliable change. The calculation of the RCI utilizes the pooled standard deviation and the
respective pooled standard deviations were used for the total and subscale score RCI
calculations. The RCI was derived using all data points from the community normal sample and
the clinical sample at baseline. The RCI for total and subscale scores are indicated in Table 3
with respective alpha levels. Table 3 also displays the sample sizes for respective groups as well
as the standard deviations and pooled standard deviations used to calculate the RCI’s.
Table 3
Reliable Change Indices
SD

RCI (alpha level)

Subscale Description

Clinical

Community

Pooled

.05

.10

Body Preoccupation

5.05

5.74

5.49

4.02

3.38

Body Dissatisfaction

2.83

5.26

4.53

3.32

2.79

Body Checking

4.18

4.61

4.46

3.91

3.28

Binge Eating

6.43

2.88

4.54

3.98

3.34

Restriction

4.36

2.61

3.35

3.60

3.02

Food Preoccupation

4.13

3.81

3.93

3.08

2.59

Vomit

2.37

0.85

1.56

2.25

1.89

Total

20.60

21.48

21.17

11.74

9.85
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Hierarchical Linear Modeling
Hierarchical linear modeling analyses were completed for the clinical sample utilizing all
data points. Time variable transformations using Tukey’s Ladder of Transformations indicated
that the regular time intervals yielded the lowest two log-likelihood (2 LL) statistics, which is a
maximum likelihood estimate measuring goodness of fit (deviance of the model of observed and
expected values). Time variable transformations of squared and square root were conducted to
ascertain the best shape of the models (see Table 4). These transformations yielded more
deviance and no further time transformations were needed as the trends of 2 LL indicated values
in the diminishing direction (greater deviance).
Table 4
Tukey’s Ladder of Transformations
Time Transformation

2 Log Likelihood

Session - Square Root

8049.99

Session (time)*

7959.14

Session - Squared

8060.95

Note. *Original time variable
Two models were generated, a model based on severity strata and a model based on
initial scores. The original HLM models included all theorized variables of the intercept,
severity strata level or initial score, diagnosis, session and strata severity or initial score
interaction, and session and diagnosis interaction. A centered method was utilized in order to
produce a more intuitive model, using middle severity and average initial scores. The stepwisedeletion method was used to eliminate variables which yielded significance levels above p = .05.
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The initial two models exhibited fairly significant results with the severity strata model
yielding all significant variables and interactions and the initial score model containing an
insignificant variable of diagnosis (p = .17). Deleting the diagnosis variable in the initial score
model and retaining variable interactions with diagnosis, the model consisted of all significant
variables. The two final models are displayed in Tables 5 and 6, including the estimates of fixed
effects values and significance levels. The initial score model produced a stronger model based
on the 2-LL estimates (see Tables 5 and 6).
Results from the HLM analyses indicated that if using the severity strata trajectories, a
patient would be expected to improve -1.82 points (decrease in score) per session (see Table 5).
The diagnosis variable differentiates between the 20 and 40 session subjects. The 40-session
patients, who were in the underweight BMI range, displayed a lower mean and the intersect
value was consequently modified for these patients by almost 15 points. These non-underweight
patients also exhibited a lower rate of change per session as the session by diagnosis interaction
modified the per session change by about two points, which resulted in a session change rate of
.40 points. Lastly, the session by severity interaction further modified the intersect point; in
specific, for higher strata nearly one point per session more change was observed.
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Table 5
Severity Strata Hierarchical Linear Model
Estimates of Fixed Effects
Confidence Interval
Parameter

Estimate

SE

df

t

p

Lower

Upper

Intercept

69.80

2.98

58.29

23.42

.01

63.84

75.77

Severity

22.37

2.31

58.59

9.69

.01

17.75

26.98

Session

-1.82

.33

41.11

-5.53

.01

-2.48

-1.16

-14.89

6.26

55.01

-2.38

.02

-27.44

-2.36

Session*Severity

-.83

.26

40.46

-3.25

.01

-1.34

-.31

Session*Diagnosis

2.22

.65

35.17

3.39

.01

.89

3.55

Diagnosis

Note. 2 Log Likelihood = 7893.61; Confidence interval using 95%.
The initial score HLM model indicated a smaller 2-log likelihood variance rate. The
initial score HLM model, as previously noted, dropped the diagnosis variable as it was not
shown to be significant (Table 6). With this variable dropped, the session change observed is
projected to be about -2.50. The rate of change was also affected by the level of initial scores,
with higher scores above the mean improving at a higher rate of -.03 and the converse with lower
scores. The diagnosis by session interaction was retained, which also indicated a decrease in
change rate for 40-session subjects by 1.83 points per session, bringing the change rate to about .8 points per session.
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Table 6
Initial Score Hierarchical Linear Model
Estimates of Fixed Effects
Confidence Interval
Parameter

Estimate

SE

df

t

p

Lower

Upper

Intercept

87.29

1.75

57.24

49.87

.01

83.79

90.79

initial

1.01

.09

57.43

11.62

.01

.83

1.18

session

-2.51

.24

43.17

-10.63

.01

-2.99

-2.04

session*initial

-.03

.01

41.81

-3.06

.01

-.06

-.01

session*diagnosis

1.83

.67

36.49

2.75

.01

.48

3.19

Note. 2 Log Likelihood = 7882.88; Confidence interval using 95%.
A macro scoring program was created to aid clinicians in the use and interpretation of
CHEDS scores. As the initial score model was the stronger model, the scoring program was
based upon this model. The CHEDS scoring program derives the total scores, subscale scores
for all seven subscales, the reliable change needed, respective cutscores, and the expected
trajectories on the total and subscale score levels with separate trajectories, each with its own
chart and graph. Upper and lower tolerance levels are also calculated using the respective RCI’s.
CHEDS and Clinical Impairment Assessment Comparison
The correlation between the CHEDS and CIA, an assessment of life functioning for those
suffering from an eating disorder, was calculated. The CIA was administered to clinical subjects
at pre-treatment, session seven, and post treatment and the correlations with the CHEDS used
those time points. The clinical sample CIA mean at pre-treatment was 38.40 and decreased to 30
at session seven. At post-treatment, the clinical sample yielded a mean score of 13.17 (Table 7).
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An ANOVA comparison of the three administrations of the CIA (pre, session 7, and post) with
each other demonstrated significant across time decreases for the total CIA scores (F ( 2, 125) =
92.21, p < .01).
Table 7
CIA Total Score Descriptives
Session

n

M

SD

Pre

57

37.00

12.12

Seven (7)

48

29.83

12.52

Post

24

13.17

10.68

The CHEDS and CIA had high correlations at each time point. At the pretreatment
session, the CHEDS and CIA total scores were correlated at .68 and increased in degree of
correlation from .78 and .89 at session 7 and post-treatment, respectively (all correlations, p <
.01). These correlations indicated that the CHEDS and CIA relate to a high degree. Changes
observed on the CHEDS in eating disorder symptomatology vary at a high rate together with the
CIA, an assessment of life functioning of those suffering from an eating disorder. Table 8
displays the correlation matrix of the CHEDS and CIA.
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Table 8
CIA-CHEDS Correlation Matrix
1

2

3

4

5

1.

CHEDS pre

2.

CIA pre

.68*

--

3.

CHEDS 7

.55*

.45*

--

4.

CIA 7

.36*

.56*

.78*

--

5.

CHEDS post

-.16

.07

.28

.61*

--

6.

CIA post

-.01

.23

.32

.59*

.89*

6

--

--

Note. Pearson correlation table with 2-tailed significance. * p < .05.
Assessment of CHEDS Clinical Significance
The clinical significance criteria determined by the RCI’s and cutscores were used to
assess change in the clinical sample during treatment. This was done by utilizing CHEDS total
and subscale scores at session 0 and the last session the subject completed, which in most cases
is session 20. The cutscore between the community normal and clinical samples for total and
subscale levels were used, as well as the respective RCI’s. The analyses consisted of calculating
the proportion of patients in each of four categories of change: clinical significant change
(recovery), reliable improvement, no change, and reliable deterioration and are displayed in
Table 9. The recovered category was comprised of only patients who were above the cutscore at
pre-treatment (session 0) and thus only those that could exhibit recovery on a given scale.
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Table 9
CHEDS Clinical Sample Change Frequencies

Recovered

Reliable
Improvement

No Change

Reliable
Deterioration

Body Preoccupation

62.22%

65.45%

29.09%

5.45%

Body Dissatisfaction

66.67%

66.04%

30.19%

3.77%

Body Checking

63.41%

60.38%

33.96%

5.66%

Binge Eating

54.55%

72.22%

24.07%

3.70%

Restriction

60.53%

62.26%

35.85%

1.89%

Food Preoccupation

57.14%

69.64%

25.00%

5.36%

Vomit

34.29%

26.92%

71.15%

1.92%

Total

75.56%

76.36%

16.36%

7.27%

Subscale

Note. The reliable improvement category included patients in the recovered category. Recovered
category only included patients above the cutscore at session 0.
The change frequency analysis indicated that 8 of the 44 subjects that displayed reliable
improvement on the total score level did not meet criteria for recovery. Of these eight subjects,
two were below the cutscore at session 0 and were not eligible for the recovered category, while
six of these subjects displayed reliable improvement but did not cross over the cutscore between
the community normal and clinical samples. At session 0, a total of five of the patients were
below the cutscore on the total CHEDS score. Two of these subjects displayed reliable change,
two had no change, and one subject indicated deterioration. The subscale level change analysis
was similar to the total change score analysis with the majority of patients exhibiting reliable
change on the CHEDS subscales. The vomit subscale displayed the lowest percentage of
patients exhibiting reliable improvement. However, 33% of patients entering treatment, although
meeting criteria for an eating disorder, did not exhibit the symptom of vomiting (see Table 2).
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Thus no change would be expected on the vomiting subscale for such patients. The subscale
RCI analyses were computed using respective reliability coefficients and thus required higher
levels of change as every subscale’s reliability was lower than the CHEDS as a whole.
Finally, a chi square analysis was conducted on the four clinical significance categories
for the total CHEDS score to determine whether there were significant differences between
change categories. The chi square analysis of the CHEDS total score change comparisons was
significant (2 (df = 3) = 48.47, p < .05). Due to the treatment administered, it was expected that
there would be a greater frequency of patients in the reliable improvement and recovery
criterion, but the expected frequency could not be approximated. The expected frequencies were
divided evenly in the chi square analysis (Table 10).
Table 10
CHEDS Clinical Sample Chi Square Analysis
Change Descriptive

Observed n

Expected n

Expected %

Residual

Recovery

34

23.5

25%

10.5

Reliable
Improvement

42

23.5

25%

18.5

No Change

9

23.5

25%

-14.5

Deterioration

4

23.5

25%

-19.5

Discussion
There currently are no comprehensive eating disorder measures that clinicians can use to
track symptom change at every session that are reliable, sensitive to change, specific enough to
provide information on various dimensions of eating disorder symptoms, and include empirically
supported psychometric change indices to determine clinically significant change. Definitions of
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clinically significant change for eating disorders have ranged from meeting criteria for an eating
disorder to arbitrary criteria of changing one or two standard deviations on a given measure.
Current diagnostic measures are also unable to address the limitations of a categorical approach
based on diagnosis to assess change and outcome, as exhibited by the difficulties with the eating
disordered not-otherwise-specified (EDNOS) category. In addition to utilizing diagnostic
measures, which can be time and labor intensive, or relying upon single dimension measures of
eating disorder symptoms, clinicians do not have a means by which to assess comprehensive
change in eating disorder symptomatology on a session-by-session basis. Diagnostic measures
are helpful in distinguishing eating disordered and non-eating disordered groups and
unidimensional measure are useful for obtaining information on specific dimensions of
symptoms, but do not maximize the effectiveness of symptom tracking or ascertaining
therapeutic outcome. The Changes in Eating Disorder Symptoms scale (CHEDS) was developed
for this purpose, though lacked empirically-validated change indices to gauge progress.
The current study sought to develop clinically significant change criteria for the Change
in Eating Disorder Symptoms scale. Cutscores were established, confirming the receiver
operator characteristics (ROC) analysis cutscore found in a previous study, reliable change
indices were created to allow for empirically based interpretation of changes in CHEDS scores,
and change trajectories were developed utilizing hierarchical linear modeling (HLM) methods.
The CHEDS was then compared to an eating disorder life functioning scale, the Clinical
Impairment Assessment (CIA), to determine the association between changes in the CHEDS
with changes in life impairment. Finally, the psychometric change indices were then used to
compare change criteria using the clinical eating disordered sample in this study.
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Tests of normal distribution of the clinical sample yielded a normal distribution.
Examining the descriptive statistics of the CHEDS obtained in this study, the means and standard
deviations appear to be indicative of two populations. The community normal sample had a
mean and standard deviation which were all significantly lower than the mean and standard
deviation for patients. The clinical sample indeed yielded higher scores than the community
normal sample, which is supported by the fact that the samples are based on eating disorder
diagnoses. This also coincides with correlations with other eating disorder diagnostic and
unidimensional measures (Spangler, 2010). The community normal sample, though, was shown
to have some cases with high scores despite not meeting criteria for an eating disorder diagnosis,
as indicated by ranges observed. The means, standard deviations, and ranges showed that there
is some overlap between the community normal and clinical samples, which were expected. As
Tingey et al. (1996) suggests, relevant normative samples should be selected for comparison that
are close in proximity to compare samples in a range of dysfunction. It is possible that a more
dysfunctional sample, such as moving from the outpatient sample used in this study to an
inpatient sample, could be used for further comparison.
Cutscores between community normal and clinical samples were derived for the total
scale and subscales of the CHEDS. The total cutscore that was derived in this study (i.e., 65)
corroborated well with the ROC analysis cutscore of 60 obtained by Spangler (2010). While the
ROC analysis ascertains the best balance of specificity and sensitivity between samples or
populations, the cutscore calculation used herein uses a different calculation that produced a
quite similar cutscore. The cutscore fell in between the patient and community sample means. In
addition to replicating the ROC analysis for total CHEDS score, cutscores for the subscale scores
were also generated which can be used to help determine clinically significant change criteria for
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each subscale of the CHEDS. The cutscores on the subscales of the CHEDS add to the utility of
the measure as scores on the subscales can now also be interpreted in the same manner as the
total scores. The cutscores also lay the groundwork to use with RCI’s to determine clinically
significant change.
Reliable change indices were established for the CHEDS total and subscale scores. The
RCI is a difference score needed to be a significant change, or change that is attributed to actual
change rather than chance. The RCI can be calibrated to varying levels of significance
determined by the stringency that a clinician or researcher prefers. The calculation of the RCI
can utilize varying alpha levels according to a clinician’s discretion to what confidence level they
desire to indicate a reliable change. As the alpha level increases, the amount of change on the
CHEDS required to be considered reliable change decreases. Not only are the RCI for total
score and subscale scores useful in indicating positive change (i.e., decrease in frequency and/or
severity of eating disorder symptoms) but also negative change or deterioration, such as an
increase in frequency and severity of eating disorder symptoms. The CHEDS subscale RCI’s
can be used to determine change similar to the total score RCI. The CHEDS RCI’s provide a
clinician with a patient’s change score that is readily interpretable. Whereas in the past a change
or difference score was perhaps compared to something like the standard deviation, the RCI can
now be used as an empirically supported change index that takes into account measurement
error, utilizing a measure’s reliability in the calculation of required change.
As a result of a high internal reliability of the CHEDS, the difference score required to be
considered reliably changed is less than the CHEDS standard deviation. As previously noted, the
more sensitive and reliable the instrument being used, less error will be observed and change is
more reliably measured. The absence of positive or negative change can also be determined if an
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individual’s initial score and final score did not achieve a positive or negative RCI.
Additionally, utilizing subscale level RCI analyses, an individual can exhibit varying levels of
change at different rates on different subscales. Change on the subscales can be examined and
are not determined by change observed on the total score level. For example, an individual with
an eating disorder measured by the CHEDS may change on certain subscales but not on all
subscales uniformly and it is possible that total score reliable improvement is achieved without
change observed on all CHEDS subscales. Similarly, certain subscales may reliably change but
an individual may not exhibit a total score reliable improvement. The amount and significance
of changes in specific symptoms can now be examined using the CHEDS. With the CHEDS and
psychometric change indices, clinicians will be able to tailor interventions and focus on relevant
areas of disturbance in an individual in an idiosyncratic manner by tracking specific symptoms
that might not be exhibiting reliable change.
Hierarchical linear modeling (HLM), a multilevel analysis, was established on the
clinical sample using the CHEDS to create trajectories based on the initial level of disturbance
on the total and subscale levels. The HLM analyses illustrated how CHEDS scores of
individuals change over time, determinant on certain variables. Tukey’s Ladder of
Transformation was completed on a simple model to determine if the time variable was to be
modified to match the shape of the trajectories. The results supported that a time variable
transformation was not needed. Two theories were used to create the models: utilizing initial
scores or initial score severity strata. In these two models, variables of time (session), diagnosis,
interaction with initial score or severity strata, and interactions with diagnosis were used. The
severity strata model produced a very low rate of change. This was likely a result of too few of
subjects per severity strata to create a viable model. Using this model, 40-session clients were
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shown to deteriorate unless they were in the high severity strata. This may be explained, though,
by the egosyntonic presentation of underweight individuals as many 40-session clients may deny
or minimize the severity of symptoms than those classified as a 20-session client. The initial
score HLM model culminated into the strongest model as the severity strata model yielded more
variance indicated by 2-Log likelihood with the diagnosis variable dropped. The HLM
calculations were constructed for all subscales and the total score.
Utilizing the cutscores, RCI’s, and the HLM trajectory calculations, a CHEDS scoring
macro program was developed. This program can be used to record responses on the CHEDS at
every session, score the CHEDS, generate subscale scores, and map out expected trajectories of
change. The program creates charts and corresponding graphs with idiosyncratic RCI values and
cutscores between the eating disordered and non-eating disordered groups with separate charts
and graphs for total and subscale scores. This program can be used to track observed scores
compared to expected scores, with the criteria for reliable improvement, recovery, deterioration,
and no change displayed in the charts and mapped onto the graphs. Instructions on how to utilize
the program are contained in the first worksheet and each other worksheet is appropriately titled.
A clinician is also able to select a 20-session model or 40-session model, which will alter the
calculations using the session by diagnosis (20 vs. 40 session subjects) interactions. Data entry
space is provided for inputting CHEDS scores on up to 40 sessions. Varying alpha levels used
for the RCI calculations can also be selected based on the discretion of the user to select a more
stringent or lenient criteria for reliable change. This program can be a useful tool to apply the
findings of this study to track symptom change and outcome of patients with eating disorders and
for clinicians to maximize the uses of these clinically significant change measures. The HLM
trajectories are visualized in the graphs and a clinician is then able to estimate when a client
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should achieve clinically significant change or if they are deviating from the projected path.
When deviations occur or if certain subscales are not changing at an expected rate, interventions
can then be tailored in treatment to help target and abate possible explanations of these issues.
Correlations between the CIA and CHEDS were calculated and the CIA and CHEDS
indicated a high correlation, strengthening over time. This finding supported the CHEDS as a
measure of eating disorder symptoms as it is expected that as symptoms decrease an increase in
life functioning, which the CIA measures, should be exhibited. This finding is consistent with
other measure comparisons from a previous examination of the CHEDS (Spangler, 2010).
The outcome of the analysis of change frequencies on the clinical sample of the CHEDS
was promising. The CBT treatment received by the clinical sample was shown to be effective.
On the CHEDS total score level, 76% exhibited reliable improvement and nearly 76% of patients
were recovered at their last session. As previously noted, the recovered category was derived
excluding patients that were below the cutscore at pretreatment while the reliable improvement
category includes patients in the recovered category. About 16% of subjects experienced no
change and 7% were seen to have deteriorated. It is to be noted that the data used in the CHEDS
analysis included all patients, which was comprised of those who were still continuing treatment
or dropped out of treatment, not just full treatment completers. This analysis used an alpha level
of .05, which is also very stringent, meaning more change was required to reach clinical
significance criteria. All subjects in the clinical sample met criteria for an eating disorder on the
EDE, though on the total score level, five patients were below the CHEDS total cutscore.
Despite the clinical and community samples being very distinct as indicated by the ANOVA, it
was expected that there would be some overlap between the samples as the samples are closest in
functioning (i.e., community normal and outpatient sample, opposed to a community normal and
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intensive inpatient sample). The overlap is exhibited in the ranges of scores observed. Similarly,
the non-eating disorder sample also exhibited elevations on some eating disorder symptoms
despite not meeting full criteria for an eating disorder. The five clinical patients who fell below
the CHEDS total cutscore may be the result of underreporting of symptoms, which may have
been circumvented on the EDE, which is interviewer-based, but not on the self-report CHEDS.
Two of these five patients were diagnosed with AN according to the EDE. Persons with AN are
likely to endorse fewer categories of symptoms as most will not have elevations on symptoms
such as binge eating or purging which may result in lower overall CHEDS scores.
CHEDS subscale level change was shown to be similar to the total score level, with the
exception of the vomit subscale. The lower level of recovery and reliable change on the vomit
subscale is likely due to several factors. First, although all patients met criteria for an eating
disorder at baseline, a large portion of the patients did not meet criteria for bulimia nervosa and
thus came into the treatment without showing elevations on the vomit subscale (33%).
Therefore, a large segment of patients fell below the vomit subscale cutoff at baseline and would
not be expected to change reliably on this subscale during treatment as there was no change to be
made. Additionally, the amount of change necessary on the vomit subscale is proportionate to its
reliability level as subscale RCI’s were calculated using respective subscale reliability levels and
are independent from the total score RCI. As a result, the vomit subscale’s initial low mean,
higher standard deviation, and lower internal reliability compared to other subscales, made the
change necessary to be considered significant on the vomit subscale large in comparison to other
subscales. Additionally, all subscales had patients who did not exceed the cutscores at baseline.
This is expected as not all patients on the eating disorder spectrum would be expected to exhibit
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every symptom on the CHEDS, nor have elevations on all subscales nor exceed the cutoff value
for all subscales.
The problematic use of the EDNOS category as a result of diagnostic measures’ inability
to distinguish well between subthreshold eating disorders and the absence of an eating disorder
diagnosis as well as limitations of non-comprehensive unidimensional measures are also
addressed by the CHEDS. The development of a dimensional, multidimensional measure, the
CHEDS, may help to circumvent the limitations of categorical definitions of change based on
diagnoses by assessing a spectrum of eating disorder symptoms with empirically validated
change indices. Making use of the CHEDS, what is considered “recovered” can be defined in
clinical significance terms of changing reliably and being more representative of a functional
than less-functional population rather than using a qualitative or arbitrary assessment of change.
This may also eliminate some of the difficulties diagnosing subthreshold eating disorders and an
absence of an eating disorder with tracking change and outcome. Tracking change and outcome
can now employ a brief but comprehensive eating disorder symptom measure which gauges
functioning of patients on a session-by-session basis, independent from diagnoses, using
solidified clinical significant change criteria.
This study utilized a clinical sample of a wide range of eating disordered subjects,
increasing the versatility of the CHEDS. In addition, the aim of developing cutscores is to have
a means of distinguishing between a community normal population and clinical eating disorder
population, rather than relying solely on diagnostic criteria. The implication of cutscore
development is providing a means for clinicians to determine if an individual’s CHEDS score is
more representative of a functional versus less functioning population. The RCI’s also stand
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apart from diagnoses as the calculations are based on empirically validated methods of using
measurement error and bearing a change value on the CHEDS that is readily interpretable.
Further, clinicians are provided with an additional promising tool in assessing paths to
recovery using HLM trajectories to predict the slope and point in time for recovery, reliable
improvement, or even gauge a lack of change or deterioration. These additional change indices
can be used on a session-by-session basis using the CHEDS, allowing clinicians treating
individuals with eating disorders to better track and gauge progress or lack thereof. The
development of the CHEDS tracking and outcome scoring program also has the potential to
make a significant impact on how clinicians are able to use this measure in everyday practice.
Study Strengths
Results of this study could have an immediate and significant impact on the utilization of
eating disorder patient evaluations of change and progress. This study has several strengths.
There is a clear operationalization of the constructs measured by the CHEDS. It has high
internal reliability, and a stable and valid subscale structure. The RCI and cutscores calculated
provide clear operationalizations of clinically significant change on the CHEDS, used in
conjunction with the trajectory analyses. The study also utilizes the CIA as another indicator of
clinically significant change, measuring life functioning for those with eating disorders,
expanding the exemplars of possible indicators of change. The CHEDS has been calibrated with
the convergent validity of the current use of outcome criteria of eating disorders: the assessment
of meeting criteria for an eating disorder at pre and post treatment using diagnostic measures.
The high concurrent validity with measures such as the EDE further validates the CHEDS as a
comprehensive measure of eating disorder symptoms.
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The strengths of the study are also rooted in the controls implemented in the study, such
as the manualized protocol used for treatment of the eating disordered patients. The reliability of
treatment implementation, for example, is indicated as a strength as there are various fidelity
checks to the manual, including pre-training, videotaped sessions, weekly supervision, and
session-by-session fidelity checks. This supports the assumption that the internal validity of the
study is high as the causal relationship between treatment and outcome is clear. Confounds such
as varying implementation of treatments and compensatory equalization of treatments are
minimized. The homogeneity of the study also increases internal validity of putative cause and
effect of the treatment of eating disorders.
Future directions of CHEDS studies should assess a larger sample size of both eating
disordered and non-eating disordered populations, also including various data collection sites.
An inpatient sample may also be used as another comparison population and cutscores generated
between outpatient and inpatient samples. This sample could also be used to determine the
trajectories and RCI calculations to increase the generalizability of the measure. Though, it is
supported that outpatient treatment is more empirically validated than inpatient treatment.
Outpatient samples are very similar to the inpatient sample except for the higher probability of
including more individuals that are underweight or meet criteria for AN, given the nature of
individuals hospitalized primarily for an eating disorder. Another possible future study could
replicate this study in a population that have utilized the scoring program using the RCI’s,
cutscores, and HLM trajectories produced from this study. This may result in improved rates of
change as clinicians would be able to utilize this tracking and outcome measure and tailor
treatments accordingly.
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Limitations
There were a few limitations of the study. The number of patients used in the study was
not large. However, for calculations such as the HLM analyses, there were several thousand data
points used and additions of more data points would likely not change the calculations in any
substantive manner. As a result of the sample size, the HLM analyses of the strata of severity
scores was not successful and can only be used as a preliminary analysis for future research.
The clinical sample consisted of fairly homogeneous individuals in terms of
demographics, with only one site for data collection, which collected the sample utilizing
convenience sampling. This homogeneity of subjects limits the generalizability of the change
metrics created to populations that do not have similar demographic characteristics. Further,
while the sample size is more than adequate for the power analysis, the proportion of anorexia
nervosa subjects was small. The analyses were based primarily on individuals with bulimia
nervosa and EDNOS. Though this is representative of the prevalence rates of eating disorders
and of treatment resistance in persons with anorexia nervosa, it also has implications of a lack of
generalizability for anorexia nervosa.
The larger treatment study from which the patient sample was drawn utilized various
other measures to evaluate treatment. This introduced the possibility of a validity threat of
interaction of testing and treatment. The various testing that each individual received may
inadvertently prime the individuals in treatment to their symptoms of eating disorders, though
this may be minimal since all patients spontaneously present to the study reporting such
symptoms.
Overall, with the psychometric change indices and trajectories produced in this study, the
eating disordered population can be better served with clinicians that will be able to better utilize
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the CHEDS as a measure of change and progress of patients. With the development of this
comprehensive, brief measure of eating disorder symptoms that can be given at each session,
these psychometric tools help maximize the potential of this measure. The psychometric change
indices and scoring program created in this study provide promising tools that have not been
applied to eating disorder treatment up to this point.
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